Aurobindo gets USFDA nod for generic cough relief tablets
New Delhi : Aurobindo Pharma said it has received final approval from the US health regulator to manufacture the generic version of Reckitt Benckiser's Mucinex DM cough relief tablets.
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg, Aurobindo Pharma said in a BSE filing.
The tablets help loosen mucus and phlegm, and thin out bronchial secretions, making cough more productive, it added.
The product will be launched in the first quarter of 2017-18, it said.
Citing IRI data, Aurobindo Pharma said the tablets had an estimated market size of USD 235 million for the 12-months ended December 2016.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd